Feature

Is kratom the answer to the opioid crisis?


 


Dr. Goldberger, Dr. Levounis, Dr. Grundmann, and Dr. Holcomb had no disclosures. Dr. Galbis-Reig disclosed in his study that he is the owner of stock in GW Pharmaceuticals and Cortex Pharmaceuticals, Pfizer bonds, and has spousal ownership of stock in AbbVie, Abbott Pharma, and Hospira. Dr. Swogger and other authors of the systematic review reported serving as consultants for the American Kratom Association, as well as sponsors of other kratom products.

Pages

Recommended Reading

What can happen if you fail to check the PDMP?
MDedge Neurology
VIDEO: How to manage surgical pain in opioid addiction treatment
MDedge Neurology
New buprenorphine formulation approved for medication-assisted treatment
MDedge Neurology
Persistent opioid use a risk after surgery in teens and young adults
MDedge Neurology
Junk food, energy drinks may damage teen brains
MDedge Neurology
Health care gets little attention in State of the Union address
MDedge Neurology
Opioid deaths in the ED increase nationally
MDedge Neurology
Opioid prescriptions got shorter in 2017
MDedge Neurology
Alcohol dependence may accelerate aging, frontal cortical deficits
MDedge Neurology
MDedge Daily News: Stem cells may reverse premature menopause
MDedge Neurology